March 17, 2015 8:59 AM | 1 min read |
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Below are the top mid-cap stocks in the healthcare sector in terms of EPS growth forecast for the next five years.
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) earnings per share growth forecast for the next five years is 46.09%. Alnylam Pharmaceuticals' trailing-twelve-month revenue is $50.60 million.
Molina Healthcare, Inc. (NYSE: MOH) EPS growth forecast for the next five years is 38.83%. Molina Healthcare's trailing-twelve-month revenue is $9.67 billion.
DexCom, Inc. (NASDAQ: DXCM) EPS growth forecast for the next five years is 32.50%. DexCom's trailing-twelve-month revenue is $259.20 million.
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) earnings per share growth forecast for the next five years is 31.81%. Acadia Healthcare's trailing-twelve-month revenue is $1.00 billion.
United Therapeutics Corporation (NASDAQ: UTHR) earnings per share growth forecast for the next five years is 30.40%. United Therapeutics' trailing-twelve-month revenue is $1.29 billion.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.